Theranoscopesp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2020-06-16
Share capital
5,000.00 PLN
Registered address
ul. Prof. Stanisława Łojasiewicza 4, 30-348 Kraków, Poland

Financials

Revenue history

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 269 days for 2022).

  • 202519/06/2026
  • 202403/07/2025
  • 202329/04/2024
  • 202209/04/2024
  • 202102/08/2022
  • 202029/06/2021
Filed on timeDelayFiling deadline

The statements for 2020 report only zeros (no activity).

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Authorized Representatives

Ewa Łucja Stępień – President of the Management Board
Paweł Moskal – Management Board Member

Manner of representation

Two members of the management board acting in agreement, or a commercial proxy acting jointly with a member of the management board; in the case of a one-person management board, the President of the Management Board personally.

Ownership

OwnerSharesShare valueStake
10$135.0610%
Agnieszka Kamińskaage 38
30$405.1930%
Ewa Łucja Stępieńage 58
60$810.3760%

Beneficial owners

Person

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
MedappS.A.
EIT Rawmaterials Clc Eastsp. z o.o.
COS LabP.S.A.
IntelliseqS.A.
Przedsiębiorstwo Wielobranżowe Genezasp. z o.o.
Medtransfersp. z o.o.
Oncotherics PolandS.A.
Fusiomicasp. z o.o.
Ncage TherapeuticsS.A.
SelvitaS.A.

FAQ

Last updated: 2026-06-19